The concept can be used broadly, for example substance misuse and depression, or it can be restricted to specify severe mental illness such as: • psychosis, • schizophrenia; • a substance misuse issue such as cannabis or methamphetamine use; • a person who has a milder mental illness such as panic disorder, anxiety disorder; or • intellectual disability such as ASD or FASD.

The concept can be used broadly, for example substance misuse and depression, or it can be restricted to specify severe mental illness such as: • psychosis, • schizophrenia; • a substance misuse issue such as cannabis or methamphetamine use; • a person who has a milder mental illness such as panic disorder, anxiety disorder; or • intellectual disability such as ASD or FASD.

The concept can be used broadly, for example substance misuse and depression, or it can be restricted to specify severe mental illness such as: • psychosis, • schizophrenia; • a substance misuse issue such as cannabis or methamphetamine use; • a person who has a milder mental illness such as panic disorder, anxiety disorder; or • intellectual disability such as ASD or FASD.

Issues such as medicinal cannabis and vaping cut across regulatory areas and we have been working with the Therapeutic Goods Administration to develop cross- regulatory solutions.

ACC intelligence alleged the men in question were involved in interstate trafficking of methylamphetamines, ecstasy and cannabis.

Failure to i eceive complaint 0 4 UZ Other 0 0 Subtotal 0 4 24 V Exercise of powers VA Harassment 6 14 VS Improper direction 1 5 VC Expired restraint order 0 0 VD Cease loiter direction 1 2 VS Intervention in civil disputes 0 0 VF Discriminatory treatment 5 27 VG Telecommunications 0 0 VZ Other 3 7 Subtotal 16 55 Firearms WA Discharge of firearms 0 0 WE Display of firearms 1 7 WC Seizure of firearms 1 4 WZ Other 1 3 Subtotal 3 14 X Control of information 24 33 XA Disclosure of confidential information XB Giving incorrect information 7 12 XC Refusal to divulge information 2 5 XD Failure to respond to enquiries 4 5 XE Privacy Information Principles 0 0 XF Freedom of Information 2 3 XZ Other 9 12 Subtotal 48 70 Y Drugs and narcotics YA Control of drugs and narcotics 0 0 YB Sale or supply of drugs 0 0 YC Personal use of drugs 2 2 YD Cannabis

for medical purposes to include the trialing of cannabis to eligible patients. ????????????????

Representativeness of online purposive samp- ling with Australian cannabis cultivators.

KANDELAARS: Another one in the annual report raised the issue that expiation notices for cannabis offences had increased and exceeded your KPI, as I understand it.

procedures UA Failure to forward complaint 0 1 UB Failure to investigate complaint 0 2 UC Failure to receive complaint 1 4 UZ Other 1 2 Subtotal 2 9 V Exercise of powers VA Harassment 12 24 VB Improper direction 2 4 VC Expired restraint order 0 0 VD Cease loiter direction 0 0 VE Intervention in civil disputes 7 11 VF Discriminatory treatment 4 7 VG Telecommunications 0 0 VZ Other 4 8 Subtotal 29 54 W Firearms WA Discharge of firearms 0 0 WB Display of firearms 2 5 WC Seizure of firearms 2 2 WZ Other 2 4 Subtotal 6 11 X Control of information XA Disclosure of confidential information 37 45 XB Giving incorrect information 11 15 XC Refusal to divulge information 1 1 XD Failure to respond to enquiries 1 2 XE Privacy Information Principles 0 0 XF Freedom of Information 10 10 Other 14 21 Subtotal 74 94 Y Drugs and narcotics YA Control of drugs and narcotics 0 0 YB Sale or supply of drugs 3 3 YC Personal use of drugs 0 0 YD Cannabis